Ewelina Kluza
Eindhoven, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapy.
Journal: Research square
Published: April 03, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapy.
Journal: Research square
Published: April 03, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironment.
Journal: Science advances
Published: January 01, 2026
Engineering Fusion Proteins for Nanomedicine-Based Cytokine Therapy.
Journal: Bioconjugate chemistry
Published: July 11, 2025
Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 11, 2025
Engineering Lipid Nanoparticles for mRNA Immunotherapy.
Journal: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Published: November 05, 2024
Targeting mTOR in myeloid cells prevents infection-associated inflammation.
Journal: iScience
Published: April 30, 2024
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors.
Journal: Nature nanotechnology
Published: October 17, 2023
Spatial Transcriptional Mapping Reveals Site-Specific Pathways Underlying Human Atherosclerotic Plaque Rupture.
Journal: Journal of the American College of Cardiology
Published: February 16, 2023
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells.
Journal: Nature biomedical engineering
Published: December 21, 2021
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy.
Journal: Nature nanotechnology
Published: September 25, 2021
Diverse ultrastructural landscape of atherosclerotic endothelium.
Journal: Atherosclerosis
Published: July 25, 2021
Last Updated: 09/26/2026